BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND DUX4L1, DUX4, P0CJ90, P0CJ89, P0CJ88, P0CJ86, P0CJ85, 22947
62 results:

  • 1. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
    Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
    Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
    Podgorica M; Drivet E; Viken JK; Richman A; Vestbøstad J; Szodoray P; Kvam AK; Wik HS; Tjønnfjord GE; Munthe LA; Frietze S; Schjerven H
    Eur J Haematol; 2024 May; 112(5):731-742. PubMed ID: 38192186
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcription factor 12-mediated self-feedback regulatory mechanism is required in dux4 fusion leukaemia.
    Li Z; Jiang M; Wang J; Zhuo Z; Zhang S; Tan Y; Hu W; Zhang H; Meng G
    Clin Transl Med; 2023 Dec; 13(12):e1514. PubMed ID: 38115701
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The impact of an additional copy of chromosome 21 in B-cell precursor acute lymphoblastic leukemia.
    Hormann FM; Mooij EJ; van de Mheen M; Beverloo HB; den Boer ML; Boer JM
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23217. PubMed ID: 38087879
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis.
    Kovach AE; Wood BL
    Semin Diagn Pathol; 2023 Nov; 40(6):457-471. PubMed ID: 37953192
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia.
    Shakah H; Tbakhi A; Khudirat S; Abweh RA; Hasasna N; Alwhaidi A; Khoujah A; Barakat F
    J Int Med Res; 2023 Oct; 51(10):3000605231203842. PubMed ID: 37818740
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. dux4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia.
    Campolungo D; Salomé M; Biferali B; Tascini AS; Gabellini D
    Sci Adv; 2023 Sep; 9(37):eadi3771. PubMed ID: 37713484
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
    Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
    J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
    Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
    Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications.
    Darzentas F; Szczepanowski M; Kotrová M; Hartmann A; Beder T; Gökbuget N; Schwartz S; Bastian L; Baldus CD; Pál K; Darzentas N; Brüggemann M
    Front Immunol; 2023; 14():1125017. PubMed ID: 37143651
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
    Leongamornlert D; Gutiérrez-Abril J; Lee S; Barretta E; Creasey T; Gundem G; Levine MF; Arango-Ossa JE; Liosis K; Medina-Martinez JS; Zuborne Alapi K; Kirkwood AA; Clifton-Hadley L; Patrick P; Jones D; O'Neill L; Butler AP; Harrison CJ; Campbell P; Patel B; Moorman AV; Fielding AK; Papaemmanuil E
    Blood Adv; 2023 Aug; 7(15):3862-3873. PubMed ID: 36867579
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
    Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
    Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.
    Ryan SL; Peden JF; Kingsbury Z; Schwab CJ; James T; Polonen P; Mijuskovic M; Becq J; Yim R; Cranston RE; Hedges DJ; Roberts KG; Mullighan CG; Vora A; Russell LJ; Bain R; Moorman AV; Bentley DR; Harrison CJ; Ross MT
    Leukemia; 2023 Mar; 37(3):518-528. PubMed ID: 36658389
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
    Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
    Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia.
    Yu CH; Jou ST; Su YH; Coustan-Smith E; Wu G; Cheng CN; Lu MY; Lin KH; Wu KH; Chen SH; Huang FL; Chang HH; Wang JL; Yen HJ; Li MJ; Chou SW; Ho WL; Liu YL; Chang CC; Lin ZS; Lin CY; Chen HY; Ni YL; Lin DT; Lin SW; Yang JJ; Ni YH; Pui CH; Yu SL; Yang YL
    Cancer; 2023 Mar; 129(5):790-802. PubMed ID: 36537587
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).
    Rehn J; Mayoh C; Heatley SL; McClure BJ; Eadie LN; Schutz C; Yeung DT; Cowley MJ; Breen J; White DL
    PLoS Genet; 2022 Oct; 18(10):e1010300. PubMed ID: 36251721
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The genomic landscape of pediatric acute lymphoblastic leukemia.
    Brady SW; Roberts KG; Gu Z; Shi L; Pounds S; Pei D; Cheng C; Dai Y; Devidas M; Qu C; Hill AN; Payne-Turner D; Ma X; Iacobucci I; Baviskar P; Wei L; Arunachalam S; Hagiwara K; Liu Y; Flasch DA; Liu Y; Parker M; Chen X; Elsayed AH; Pathak O; Li Y; Fan Y; Michael JR; Rusch M; Wilkinson MR; Foy S; Hedges DJ; Newman S; Zhou X; Wang J; Reilly C; Sioson E; Rice SV; Pastor Loyola V; Wu G; Rampersaud E; Reshmi SC; Gastier-Foster J; Guidry Auvil JM; Gesuwan P; Smith MA; Winick N; Carroll AJ; Heerema NA; Harvey RC; Willman CL; Larsen E; Raetz EA; Borowitz MJ; Wood BL; Carroll WL; Zweidler-McKay PA; Rabin KR; Mattano LA; Maloney KW; Winter SS; Burke MJ; Salzer W; Dunsmore KP; Angiolillo AL; Crews KR; Downing JR; Jeha S; Pui CH; Evans WE; Yang JJ; Relling MV; Gerhard DS; Loh ML; Hunger SP; Zhang J; Mullighan CG
    Nat Genet; 2022 Sep; 54(9):1376-1389. PubMed ID: 36050548
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia.
    Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
    J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.